Randy Hubbell

Randy Hubbell

Director Ejecutivo en
Carmell Regen Med Corp.
.
63 años
Health Technology
Consumer Services
Commercial Services

Perfil

Randy Hubbell currently works at Carmell Regen Med Corp., as President, Chief Executive Officer & Director from 2016 and Neuraptive Therapeutics, Inc., as Director.
Mr. Hubbell also formerly worked at Longevity Health Holdings, Inc., as President, Chief Executive Officer & Director, Vasca, Inc., as Executive Director-Sales & Marketing in 2000, Cordis Cardiology, as Executive Director-Strategic Alliances, International Business Machines Corp., as Principal in 1993, Johnson & Johnson, as Principal, Boston Scientific Corp., as Principal in 1998, Enmedia, Inc., as Principal, Cardiva Medical, Inc., as Chief Commercial Officer, Johnson & Johnson Pharmaceutical Group, as Vice President-Global Strategic Marketing, and Ethicon Biosurgery Ireland, as Vice President-Global Strategic Marketing.
Mr. Hubbell received his Masters Business Admin degree from Loyola University New Orleans and undergraduate degree from Tulane University (Louisiana).

Cargos activos de Randy Hubbell

EmpresasCargoInicio
Director Ejecutivo 16/02/2016
Director/Miembro de la Junta -

Antiguos cargos conocidos de Randy Hubbell.

EmpresasCargoFin
LONGEVITY HEALTH HOLDINGS, INC. Director Ejecutivo 31/08/2023
Ventas & Marketing 01/01/2000
BOSTON SCIENTIFIC CORPORATION Corporate Officer/Principal 01/01/1998
IBM Corporate Officer/Principal 01/01/1993
Enmedia, Inc.
Corporate Officer/Principal -
Ver el detalle de la experiencia de Randy Hubbell.

Formación de Randy Hubbell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

88

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Technology Services

Health Technology

Health Technology

Health Technology

Enmedia, Inc.

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Johnson & Johnson Pharmaceutical Group

Ethicon Biosurgery Ireland

Commercial Services

Finance

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN